---
title: "Urgent BEP chemotherapy in advanced primary mediastinal malignant germ cell tumor: Case and review"
id: "pubmed-43063085"
canonical_url: "https://medichelpline.com/clinical-feed/pubmed-43063085"
content_type: "clinical_feed_article"
specialty: "Critical Care"
source_name: "PubMed / NCBI"
source_url: "https://pubmed.ncbi.nlm.nih.gov/43063085/"
doi: "10.1097/MD.0000000000051609"
published_at: "2026-11-20T00:00:00.000Z"
evidence_level: "Journal Article"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Urgent BEP chemotherapy in advanced primary mediastinal malignant germ cell tumor: Case and review
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/pubmed-43063085
- **Specialty:** [Critical Care](https://medichelpline.com/clinical-feed/critical-care.md)
- **Primary Source:** PubMed / NCBI
- **Source URL:** [Original Journal Publication](https://pubmed.ncbi.nlm.nih.gov/43063085/)
- **DOI:** [10.1097/MD.0000000000051609](https://doi.org/10.1097%2FMD.0000000000051609)
- **Published At:** 2026-11-20T00:00:00.000Z
- **Evidence Rating:** Journal Article
## Executive GIST (TL;DR)
- A 13-year-old boy presented with chest tightness, cough, and intermittent low-grade fever and was found to have a large mediastinal mass with pulmonary nodules on CT. - Serum beta-human chorionic gonadotropin was markedly elevated; biopsy confirmed an advanced **primary mediastinal malignant germ cell tumor** (PMMGCT) with lung metastases. - The patient deteriorated to acute heart failure and respiratory failure and was transferred to the intensive care unit (ICU). - The multidisciplinary team administered urgent **BEP** chemotherapy (bleomycin, etoposide, cisplatin) alongside organ support; the source reported clinical recovery and long-term survival. - The article is a case report plus literature review; investigators reported that urgent chemotherapy is increasingly used in hematologic malignancies but remains uncommon for solid tumors such as PMMGCTs. - The source did not report specific chemotherapy dosing, exact timing from admission to first cycle, detailed organ-support protocols, or quantified survival intervals beyond “long-term survival.” - Authors attributed the positive outcome to close collaboration between oncologists and intensivists and reviewed prior literature supporting feasibility but noted limited case numbers and heterogeneity in published reports. - Key clinical questions remain: selection criteria for urgent chemotherapy in solid tumors, risk–benefit thresholds during organ failure, and standardized ICU chemotherapy protocols—these were identified as unresolved in the source.
## Clinical Analysis & Structured Key Points
Clipboard, Search History, and several other advanced features are temporarily unavailable. [ Skip to main page content ](https://pubmed.ncbi.nlm.nih.gov/43063085/#article-details) ### NIH Websites Are Changing * [Get the Latest Updates and FAQs on the transition](https://www.nih.gov/web-modernization) * Per [Executive Order 14434](https://www.whitehouse.gov/presidential-actions/2026/09/inaugurating-the-era-of-super-intelligence/), federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition. ![U.S. flag](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png) An official website of the United States government Here's how you know ![Dot gov](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg) **The .gov means it’s official.** Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site. ![Https](https://cdn.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg) **The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. [ ![NIH NLM Logo](https://cdn.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg) ](https://www.ncbi.nlm.nih.gov/) [Log in](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43063085%2F) Show account info Close #### Account Logged in as: **username** * [Dashboard](https://www.ncbi.nlm.nih.gov/myncbi/) * [Publications](https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/) * [Account settings](https://www.ncbi.nlm.nih.gov/account/settings/) * [Log out](https://www.ncbi.nlm.nih.gov/account/signout/?back_url=https%3A//pubmed.ncbi.nlm.nih.gov/43063085/) [Access keys](https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys) [NCBI Homepage](https://www.ncbi.nlm.nih.gov) [MyNCBI Homepage](https://pubmed.ncbi.nlm.nih.gov/myncbi/) [Main Content](https://pubmed.ncbi.nlm.nih.gov/43063085/#maincontent) [Main Navigation](https://pubmed.ncbi.nlm.nih.gov/43063085/) [ ![pubmed logo](https://cdn.ncbi.nlm.nih.gov/pubmed/a447896c-976f-490b-b86b-2668b65114a8/core/images/pubmed-logo-blue.svg) ](https://pubmed.ncbi.nlm.nih.gov/) [ ](https://pubmed.ncbi.nlm.nih.gov/43063085/ "Show search bar") Search: [](https://pubmed.ncbi.nlm.nih.gov/43063085/ "Clear search input")Search [Advanced](https://pubmed.ncbi.nlm.nih.gov/advanced/) [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/clipboard/) [ User Guide ](https://pubmed.ncbi.nlm.nih.gov/help/) Save Email Send to * [ Clipboard ](https://pubmed.ncbi.nlm.nih.gov/43063085/) * [My Bibliography](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43063085%2F%23open-bibliography-panel) * [Collections](https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpubmed.ncbi.nlm.nih.gov%2F43063085%2F%23open-collections-panel) * [Citation manager](https://pubmed.ncbi.nlm.nih.gov/43063085/) Display options Display options Format Abstract PubMed PMID ## Save citation to file Format: Summary (text) PubMed PMID Abstract (text) CSV Create file Cancel ## Email citation Email address has not been verified. Go to [ My NCBI account settings ](https://account.ncbi.nlm.nih.gov/settings/) to confirm your email and then refresh this page. To: Subject: Body: Format: Summary Summary (text) Abstract Abstract (text) MeSH and other data Send email Cancel ### Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43063085/) Add Cancel ### Add to My Bibliography * My Bibliography Unable to load your delegates due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43063085/) Add Cancel ## Your saved search Name of saved search: Search terms: [Test search terms](https://pubmed.ncbi.nlm.nih.gov/43063085/) Would you like email updates of new search results? Saved Search Alert Radio Buttons * Yes * No Email: ([change](https://www.ncbi.nlm.nih.gov/account/settings/)) Frequency: Monthly Weekly Daily Which day? The first Sunday The first Monday The first Tuesday The first Wednesday The first Thursday The first Friday The first Saturday The first day The first weekday Which day? Sunday Monday Tuesday Wednesday Thursday Friday Saturday Report format: Summary Summary (text) Abstract Abstract (text) PubMed Send at most: 1 item 5 items 10 items 20 items 50 items 100 items 200 items Send even when there aren't any new results Optional text in email: Save Cancel ## Create a file for external citation management software Create file Cancel ## Your RSS Feed Name of RSS Feed: Number of items displayed: 5 10 15 20 50 100 Create RSS Cancel RSS Link Copy ### Actions Cite Collections Add to Collections * Create a new collection * Add to an existing collection Name your collection: Name must be less than 100 characters Choose a collection: Unable to load your collection due to an error [Please try again](https://pubmed.ncbi.nlm.nih.gov/43063085/) Add Cancel Permalink Permalink Copy Display options Display options Format Abstract PubMed PMID ### Experimental Resource Linked Discoveries ### Page navigation * [ Title & authors ](https://pubmed.ncbi.nlm.nih.gov/43063085/#heading) * [ Abstract ](https://pubmed.ncbi.nlm.nih.gov/43063085/#abstract) * [ Conflict of interest statement ](https://pubmed.ncbi.nlm.nih.gov/43063085/#conflict-of-interest) * [ References ](https://pubmed.ncbi.nlm.nih.gov/43063085/#references) * [ Publication types ](https://pubmed.ncbi.nlm.nih.gov/43063085/#publication-types) * [ MeSH terms ](https://pubmed.ncbi.nlm.nih.gov/43063085/#mesh-terms) * [ Substances ](https://pubmed.ncbi.nlm.nih.gov/43063085/#substances) * [ Supplementary concepts ](https://pubmed.ncbi.nlm.nih.gov/43063085/#supplementary-concepts) Title & authors Abstract Conflict of interest statement References Publication types MeSH terms Substances Supplementary concepts Review Medicine (Baltimore) Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Medicine+%28Baltimore%29%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Medicine+%28Baltimore%29%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43063085/) . 2026 Nov 20;105(47):e51609. doi: 10.1097/MD.0000000000051609. # Urgent chemotherapy for advanced mediastinal malignant germ cell tumor: A case report and literature review [Chao Wang](https://pubmed.ncbi.nlm.nih.gov/?term=Wang+C&cauthor_id=43063085)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43063085/#full-view-affiliation-1 "Department of Critical Care Medicine, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu, China."), [Yihao Ji](https://pubmed.ncbi.nlm.nih.gov/?term=Ji+Y&cauthor_id=43063085)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43063085/#full-view-affiliation-1 "Department of Critical Care Medicine, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu, China."), [Guohao Xia](https://pubmed.ncbi.nlm.nih.gov/?term=Xia+G&cauthor_id=43063085)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43063085/#full-view-affiliation-2 "Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu, China."), [Shuliang Ma](https://pubmed.ncbi.nlm.nih.gov/?term=Ma+S&cauthor_id=43063085)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43063085/#full-view-affiliation-1 "Department of Critical Care Medicine, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu, China.") Affiliations Expand ### Affiliations * 1 Department of Critical Care Medicine, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu, China. * 2 Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu, China. * PMID: **43063085** * DOI: [ 10.1097/MD.0000000000051609 ](https://doi.org/10.1097/md.0000000000051609) Item in Clipboard Review # Urgent chemotherapy for advanced mediastinal malignant germ cell tumor: A case report and literature review Chao Wang et al. Medicine (Baltimore). 2026. Show details Display options Display options Format Abstract PubMed PMID Medicine (Baltimore) Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Medicine+%28Baltimore%29%22%5Bjour%5D&sort=date&sort_order=desc) * [ Search in NLM Catalog ](https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Medicine+%28Baltimore%29%22%5BTitle+Abbreviation%5D) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43063085/) . 2026 Nov 20;105(47):e51609. doi: 10.1097/MD.0000000000051609. ### Authors [Chao Wang](https://pubmed.ncbi.nlm.nih.gov/?term=Wang+C&cauthor_id=43063085)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43063085/#short-view-affiliation-1 "Department of Critical Care Medicine, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu, China."), [Yihao Ji](https://pubmed.ncbi.nlm.nih.gov/?term=Ji+Y&cauthor_id=43063085)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43063085/#short-view-affiliation-1 "Department of Critical Care Medicine, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu, China."), [Guohao Xia](https://pubmed.ncbi.nlm.nih.gov/?term=Xia+G&cauthor_id=43063085)[ 2 ](https://pubmed.ncbi.nlm.nih.gov/43063085/#short-view-affiliation-2 "Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu, China."), [Shuliang Ma](https://pubmed.ncbi.nlm.nih.gov/?term=Ma+S&cauthor_id=43063085)[ 1 ](https://pubmed.ncbi.nlm.nih.gov/43063085/#short-view-affiliation-1 "Department of Critical Care Medicine, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu, China.") ### Affiliations * 1 Department of Critical Care Medicine, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu, China. * 2 Department of Medical Oncology, Jiangsu Cancer Hospital, Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital, Nanjing, Jiangsu, China. * PMID: **43063085** * DOI: [ 10.1097/MD.0000000000051609 ](https://doi.org/10.1097/md.0000000000051609) Item in Clipboard Cite Display options Display options Format Abstract PubMed PMID Linked Discoveries ## Abstract **Rationale:** Urgent chemotherapy is increasingly considered feasible for critically ill patients with hematological malignancies, although its role in solid tumors remains controversial. Primary mediastinal malignant germ cell tumors (PMMGCTs) are rare and aggressive malignancies, with limited reported cases of urgent chemotherapy in these patients. **Patient concerns:** A 13-year-old boy was admitted to the hospital with chest tightness, cough, and intermittent low-grade fever. **Diagnoses:** Computed tomography revealed a large mediastinal mass invading adjacent cardiac vessels and the anterior chest wall, along with multiple bilateral pulmonary nodules. Laboratory tests showed a significant increase in serum human chorionic gonadotropin (β-HCG) levels. Based on histopathological examination of biopsy specimens, the patient was diagnosed with advanced PMMGCT complicated by pulmonary metastases. **Interventions:** Subsequently, the patient was transferred to the intensive care unit for acute heart failure and respiratory failure and received urgent BEP chemotherapy (bleomycin, etoposide, cisplatin) and organ support therapy. **Outcomes:** During subsequent treatment follow-up, the patient recovered well and achieved long-term survival. **Lessons:** This case highlights the feasibility of urgent chemotherapy for PMMGCTs complicated by organ failure, which is attributed to close collaboration between oncologists and intensivists. **Keywords:** case report; multidisciplinary collaboration; organ failure; primary mediastinal malignant germ cell tumors; urgent chemotherapy. Copyright © 2026 the Author(s). Published by Wolters Kluwer Health, LLC. [PubMed Disclaimer](https://pubmed.ncbi.nlm.nih.gov/disclaimer/) ## Conflict of interest statement The authors have no conflicts of interest to declare. ## References 1. 1. de Oliveira MCF, Ferreira JC, Junior APN, Dettino ALA, Caruso P. Impact of urgent chemotherapy in critically ill patients. J Intensive Care Med. 2020;35:347–53. 2. 1. Pitello N, Treon M, Jones KL, Kiel PJ. Approaches for administering chemotherapy in the intensive care unit. Curr Drug Saf. 2010;5:22–32. 3. 1. Pastores SM, Goldman DA, Shaz DJ, et al. Characteristics and outcomes of patients with hematologic malignancies receiving chemotherapy in the intensive care unit. Cancer. 2018;124:3025–36. 4. 1. Kanji S, MacLean E, Rashid FJ, et al. Chemotherapy in the intensive care unit: an evaluation of context and outcomes. Can J Hosp Pharm. 2020;73:279–87. 5. 1. Bernard J, Vacheron CH, Vantard N, et al. Outcome and factors associated with mortality in patients receiving urgent chemotherapy in the ICU: a retrospective study. J Crit Care. 2023;78:154399. Show all 23 references ## Publication types * Case Reports Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Case+Reports%22%5Bpt%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Case+Reports) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43063085/) * Review Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Review%22%5Bpt%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Review) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43063085/) ## MeSH terms * Adolescent Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Adolescent%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Adolescent) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43063085/) * Antineoplastic Combined Chemotherapy Protocols* / administration & dosage Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Antineoplastic+Combined+Chemotherapy+Protocols%2Fadministration+and+dosage%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Antineoplastic+Combined+Chemotherapy+Protocols) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43063085/) * Antineoplastic Combined Chemotherapy Protocols* / therapeutic use Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Antineoplastic+Combined+Chemotherapy+Protocols%2Ftherapeutic+use%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Antineoplastic+Combined+Chemotherapy+Protocols) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43063085/) * Bleomycin / administration & dosage Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Bleomycin%2Fadministration+and+dosage%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Bleomycin) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43063085/) * Bleomycin / therapeutic use Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Bleomycin%2Ftherapeutic+use%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Bleomycin) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43063085/) * Chorionic Gonadotropin, beta Subunit, Human / blood Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Chorionic+Gonadotropin%2C+beta+Subunit%2C+Human%2Fblood%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Chorionic+Gonadotropin%2C+beta+Subunit%2C+Human) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43063085/) * Cisplatin / administration & dosage Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Cisplatin%2Fadministration+and+dosage%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Cisplatin) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43063085/) * Cisplatin / therapeutic use Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Cisplatin%2Ftherapeutic+use%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Cisplatin) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43063085/) * Etoposide / administration & dosage Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Etoposide%2Fadministration+and+dosage%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Etoposide) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43063085/) * Etoposide / therapeutic use Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Etoposide%2Ftherapeutic+use%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Etoposide) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43063085/) * Humans Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Humans%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Humans) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43063085/) * Lung Neoplasms* / drug therapy Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Lung+Neoplasms%2Fdrug+therapy%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Lung+Neoplasms) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43063085/) * Lung Neoplasms* / secondary Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Lung+Neoplasms%2Fsecondary%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Lung+Neoplasms) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43063085/) * Male Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Male%22%5BMeSH%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Male) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43063085/) * Mediastinal Neoplasms* / diagnostic imaging Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Mediastinal+Neoplasms%2Fdiagnostic+imaging%22%5BMAJR%5D&sort=date&sort_order=desc) * [ Search in MeSH ](https://www.ncbi.nlm.nih.gov/mesh?term=Mediastinal+Neoplasms) * [ Add to Search ](https://pubmed.ncbi.nlm.nih.gov/43063085/) * Mediastinal Neoplasms* / drug therapy Actions * [ Search in PubMed ](https://pubmed.ncbi.nlm.nih.gov/?term=%22Mediastinal+Neoplasms%2Fdrug+therapy%22%5BMAJR%5D&sort=d
## Related Clinical Research

- [Avoiding Cardiac Toxicity with Immune Checkpoint Inhibitors: Safety Review (Title Only Available)](https://medichelpline.com/clinical-feed/frontiers-in-immunology-15-avoidance-of-cardiac-toxicity-during-the-application-of-immune-checkpoint.md)
- [Medication Burden, Drug Interactions and Acute Kidney Injury in Critically Ill Cancer Patients](https://medichelpline.com/clinical-feed/pubmed-43006428.md) (DOI: 10.1177/10781552261506996)
- [Machine Learning–Defined LUAD Subtypes and RRM2 Linked to Cisplatin Resistance](https://medichelpline.com/clinical-feed/pubmed-42958928.md) (DOI: 10.1111/1759-7714.70407)
- [Correction: Image replacement and data notes for niosomal cisplatin–vorinostat formulation](https://medichelpline.com/clinical-feed/plos-one-19-correction-development-of-niosomal-nanoparticles-loaded-with-cisplatin-and.md)
- [Pollen size shifts after whole genome duplication in autotetraploids](https://medichelpline.com/clinical-feed/biorxiv-17-biased-evolution-of-pollen-size-after-whole-genome-duplication.md)

## Navigation
- [← Back to Critical Care Feed](https://medichelpline.com/clinical-feed/critical-care.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.